Predictors of serious infections in rheumatoid arthritis(RA).

被引:0
|
作者
Doran, MF
Crowson, CS
O'Fallon, WM
Gabriel, SE
机构
来源
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
405
引用
收藏
页码:S134 / S134
页数:1
相关论文
共 50 条
  • [31] Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab
    Hoshi, Daisuke
    Nakajima, Ayako
    Inoue, Eisuke
    Shidara, Kumi
    Sato, Eri
    Kitahama, Mariko
    Seto, Yohei
    Tanaka, Eiichi
    Urano, Wako
    Ichikawa, Naomi
    Koseki, Yumi
    Momohara, Shigeki
    Taniguchi, Astuo
    Nishimoto, Norihiro
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 122 - 127
  • [32] Opioid Analgesics and the Risk of Serious Infections among Patients with Rheumatoid Arthritis
    Wiese, Andrew D.
    Griffin, Marie R.
    Stein, C. Michael
    Mitchell, Edward F., Jr.
    Grijalva, Carlos G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 232 - 233
  • [33] Serious infections in rheumatoid arthritis. What is the scope of the problem.
    Ramey, DR
    Rausch, PL
    Schettler, JD
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S279 - S279
  • [34] Risk of serious infection in a large us cohort of patients with rheumatoid arthritis (RA) treated with common RA therapies
    Napalkov, F.
    Dube, T.
    Taylor, M.
    Wagner, B.
    Yocum, D.
    Dong, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 332 - 333
  • [35] Assessing the Rate of Serious Infections in Rheumatoid Arthritis (RA) Patients who Receive Other Biologic Therapies after Discontinuing Rituximab (RTX)
    Genovese, M.
    Cividino, A.
    Keystone, E.
    Breedveld, F.
    Emery, P.
    Cohen, S.
    Matteson, E.
    Burke, L.
    Chai, A.
    Reiss, W.
    Sweetser, M.
    Shaw, T.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1165 - 1165
  • [36] Predictive Risk Factors of Serious Infections in RA Patients Treated with Abatacept in Real Life: Results in the Orencia and Rheumatoid Arthritis (ORA) Registry
    Gottenberg, Jacques-Eric
    Ravaud, Philippe
    Cantagrel, Alain G.
    Combe, Bernard
    Flipo, Rene-Marc
    Schaeverbeke, Thierry
    Houvenagel, Eric
    Gaudin, Philippe
    Loeuille, Damien
    Rist, Stephanie
    Dougados, Maxime
    Sibilia, Jean
    Le Loet, Xavier
    Marcelli, Christian
    Bardin, Thomas
    Pane, Isabelle
    Perrodeau, Elodie
    Baron, Gabriel
    Mariette, Xavier
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S562 - S562
  • [37] Burden of non-serious infections during biological use for rheumatoid arthritis
    Bergmans, Barbara
    Jessurun, Naomi
    van Lint, Jette
    Murk, Jean-Luc
    van Puijenbroek, Eugene
    de Vries, Esther
    PLOS ONE, 2024, 19 (02):
  • [38] The development of fibromyalgia - I: Examination of rates and predictors in patients with rheumatoid arthritis (RA)
    Wolfe, Frederick
    Haeuser, Winfried
    Hassett, Afton L.
    Katz, Robert S.
    Walitt, Brian T.
    PAIN, 2011, 152 (02) : 291 - 299
  • [39] Serious infections in a population-based cohort of older individuals with rheumatoid arthritis
    Bernatsky, Sasha
    Paterson, Mike
    Hux, Jail
    Cividino, Alf
    Pope, Janet
    Thorne, Carter
    Bombardier, Claire
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S270 - S270
  • [40] Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis
    Bernatsky, S.
    Hudson, M.
    Suissa, S.
    RHEUMATOLOGY, 2007, 46 (07) : 1157 - 1160